Lack of involvement of neuronal nitric oxide synthase in the pathogenesis of a transgenic mouse model of familial amyotrophic lateral sclerosis

Neuroscience

Volumn 90, Issue 4, 1999, Pages 1483-1492

  Facchinetti, F ^a   Sasaki, M ^a   Cutting, F B ^b   Zhai, P ^b   MacDonald, J E ^c   Reif, D ^c   Beal, M F ^d   Huang, P L ^d   Dawson, T M ^a   Gurney, M E ^b   Dawson, V L ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b Ctrl Nerv Syst Dis Res P   (United States)

^c PO Box 20890   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Amyotrophic lateral sclerosis; AR R 17,477; Copper zinc superoxide dismutase; Nitric oxide; Peroxynitrite; Transgenic mice

Indexed keywords

7 NITROINDAZOLE; COPPER ZINC SUPEROXIDE DISMUTASE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FAMILIAL DISEASE; IMMUNOBLOTTING; MOUSE; MOUSE MUTANT; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOUTHERN BLOTTING; TRANSGENIC MOUSE;

AMIDINES; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; CATALYSIS; ENZYME INHIBITORS; INDAZOLES; ISOENZYMES; MICE; MICE, TRANSGENIC; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; PHENOTYPE; SPINAL CORD;

EID: 0032954386     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00492-8     Document Type: Article

References (69)

1. Abe K., Pan L. H., Watanabe M., Kato T., Itoyama Y. Induction of nitrotyrosine-like immunoreactivity in the lower motor neuron of amyotrophic lateral sclerosis. Neurosci. Lett. 199:1995;152-154.
2. Adamson D. C., Wildemann B., Sasaki M., Glass J. D., McArthur J. C., Christov V. I., Dawson T. M., Dawson V. L. Induction of immunologic nitric oxide synthase in AIDS dementia. Science. 274:1996;1917-1921.
3. Beal M. F., Ferrante R. J., Browne S. E., Matthews R. T., Kowall N. W., Brown R. H. Jr. Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis. Ann. Neurol. 42:1997;644-654.
4. Beckman J. S., Ischiropoulos H., Zhu L., van der Woerd M., Smith C., Chen J., Harrison J., Martin J. C., Tsai M. Kinetics of superoxide dismutase and iron catalyzed nitration of phenolics by peroxynitrite. Archs Biochem. Biophys. 298:1992;438-445.
5. Beckman J. S., Carson M., Smith C. D., Koppenol W. H. ALS, SOD and peroxynitrite. Nature. 364:1993;584.
6. Beckman J. S., Chen J., Crow J. P., Ye Y. Z. Reactions of nitric oxide, superoxide and peroxynitrite with superoxide dismutase in neurodegeneration. Prog. Brain Res. 103:1994;371-380.
7. Bo L., Dawson T. M., Wesselingh S., Mork S., Choi S., Kong P. A., Hanley D., Trapp B. D. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann. Neurol. 36:1994;778-786.
8. Borchelt D. R., Guarnieri M., Wong P. C., Lee M. K., Slunt H. S., Xu Z. S., Sisodia S. S., Price D. L., Cleveland D. W. Superoxide dismutase 1 subunits with mutations linked to familial amyotrophic lateral sclerosis do not affect wild-type subunit function. J. biol. Chem. 70:1995;3234-3238.
9. Bredt D. S., Snyder S. H. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc. natn. Acad. Sci. U.S.A. 87:1990;682-685.
10. Bredt D. S., Snyder S. H. Nitric oxide: a physiologic messenger molecule. A. Rev. Biochem. 63:1994;175-195.
11. Brenman J. E., Chao D. S., Gee S. H., McGee A. W., Craven S. E., Santillano D. R., Wu Z., Huang F., Xia H., Peters M. F., Froehner S. C., Bredt D. S. Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and 1-syntrophin mediated by PDZ domains. Cell. 84:1996;757-767.
12. Bruijn L. I., Becher M. W., Lee M. K., Anderson K. L., Jenkins N. A., Copeland N. G., Sisodia S. S., Rothstein J. D., Borchelt D. R., Price D. L., Cleveland D. W. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron. 18:1997;327-338.
13. Bruijn L. I., Beal M. F., Becher M. W., Schulz J. B., Wong P. C., Price D. L., Cleveland D. W. Elevated free nitrotyrosine levels, but not protein-bound nitrotyrosine or hydroxyl radicals, throughout amyotrophic lateral sclerosis (ALS)-like disease implicate tyrosine nitration as an aberrant in vivo property of one familial ALS-linked superoxide dismutase 1 mutant. Proc. natn. Acad. Sci. U.S.A. 94:1997;7606-7611.
14. w-nitro-L-arginine after focal cerebral ischemia in the mouse and inhibition of cortical nitric oxide synthase. Eur. J. Pharmac. 256:1994;241-249.
15. Chan P. H., Epstein C. J., Kinouchi H., Kamii H., Imaizumi S., Yang G., Chen S. F., Gafni J., Carlson E. SOD-1 transgenic mice as a model for studies of neuroprotection in stroke and brain trauma. Ann. N. Y. Acad. Sci. 738:1994;93-103.
16. Crow J. P., Beckman J. S. The role of peroxynitrite in nitric oxide-mediated toxicity. Curr. Top. Microbiol. Immun. 196:1995;57-73.
17. Crow J. P., Ye Y. Z., Strong M., Kirk M., Barnes S., Beckman J. S. Superoxide dismutase catalyzes nitration of tyrosines by peroxynitrite in the rod and head domains of neurofilament-L. J. Neurochem. 69:1997;1945-1953.
18. Crow J. P., Sampson J. B., Zhuang Y., Thompson J. A., Beckman J. S. Decreased zinc affinity of amyotrophic lateral sclerosis-associated superoxide dismutase mutants leads to enhanced catalysis of tyrosine nitration by peroxynitrite. J. Neurochem. 69:1997;1936-1944.
19. Dalkara T., Yoshida T., Irikura K., Moskowitz M. A. Dual role of nitric oxide in focal cerebral ischemia. Neuropharmacology. 33:1994;1447-1452.
20. Dawson D. A. Nitric oxide and focal cerebral ischemia: multiplicity of actions and diverse outcome. Cerebrovasc. Brain Metab. Rev. 6:1994;299-324.
21. Dawson T. M., Snyder S. H. Gases as biological messengers: nitric oxide and carbon monoxide in the brain. J. Neurosci. 14:1994;5147-5159.
22. Dawson V. L., Dawson T. M. Free radicals and neuronal cell death. Cell Death Differ. 3:1996;71-78.
23. Dawson V. L., Kizushi V. M., Huang P. L., Snyder S. H., Dawson T. M. Resistance to neurotoxicity in cortical neuronal cultures from neuronal nitric oxide synthase deficient mice. J. Neurosci. 16:1996;2479-2487.
24. Deng H. X., Hentati A., Tainer J. A., Iqbal Z., Cayabyab A., Hung W. Y., Getzoff E. D., Hu P., Herzfeldt B., Roos R. P., Warner C., Deng G., Soriano E., Smyth C., Parge H. E., Ahmed A., Roses A. D., Halwlewell R. A., Pericak-Vance M., Siddique T. Amyotrophic lateral sclerosis and structural defects in Cu, Zn superoxide dismutase. Science. 261:1993;1047-1051.
25. Dinerman J. L., Dawson T. M., Schell M. J., Snowman A., Snyder S. H. Endothelial nitric oxide synthase localized to hippocampal pyramidal cells: implications for synaptic plasticity. Proc. natn. Acad. Sci. U.S.A. 91:1994;4214-4218.
26. Eliasson M. J. L., Balackshaw S., Schell M. J., Snyder S. H. Neuronal nitric oxide synthase alternatively spliced forms: prominent functional localizations in the brain. Proc. natn. Acad. Sci. U.S.A. 94:1997;3396-3401.
27. Ferrante R. J., Shinobu L. A., Schulz J. B., Matthews R. T., Thomas C. E., Kowall N. W., Gurney M. E., Beal M. F. Increased 3-nitrotyrosine and oxidative damage in mice with a human Cu, Zn superoxide dismutase mutation. Ann. Neurol. 42:1997;326-334.
28. Fujisawa H., Ogura T., Kurashima Y., Yokoyama T., Yamashita J., Esumi H. Expression of two types of nitric oxide synthase mRNA in human neuroblastoma cell lines. J. Neurochem. 3:1994;140-145.
29. Garthwaite J., Boulton C. L. Nitric oxide signaling in the central nervous system. A. Rev. Physiol. 57:1995;683-706.
30. Gonzalez-Zulueta M., Yun H.-Y., Dawson V. L., Dawson T. M. Nitric oxide mediates activity-dependent neuronal survival. Soc. Neurosci. Abstr. 23:1997;630.
31. Gurney M. E., Pu H., Chiu A. Y., Dal Canto M. C., Polchow C. Y., Alexander D. D., Caliendo J., Hentati A., Kwon Y. W., Deng H. X., Chen W., Zhai P., Sufit R. L., Siddique T. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science. 264:1994;1772-1775.
32. Gurney M. E., Cutting F. B., Zhai P., Doble A., Taylor C. P., Andrus P. K., Hall E. D. Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis. Ann. Neurol. 39:1996;147-157.
33. Hall A. V., Antoniou H., Wang Y., Cheung A. H., Arbus A. M., Olson S. L., Lu W. C., Kau C. L., Marsden P. A. J. Structural organization of the human neuronal nitric oxide synthase gene (NOS1). J. biol. Chem. 269:1994;33,082-33,090.
34. Hottinger A. F., Fine E. G., Gurney M. E., Zurn A. D., Aebischer P. The copper chelator D-penicillamine delays onset of disease and extends survival in a transgenic mouse model of familial amyotrophic lateral sclerosis. Eur. J. Neurosci. 9:1997;1548-1551.
35. Huang P. L., Dawson T. M., Bredt D. S., Snyder S. H., Fishman M. C. Targeted disruption of the neuronal nitric oxide synthase gene. Cell. 75:1993;1273-1286.
36. Huang Z., Huang P. L., Panahian N., Dalkara T., Fishman M. C., Moskowitz M. A. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science. 265:1994;1883-1885.
37. Iadecola C., Zhang F., Xu S., Casey R., Ross M. E. Inducible nitric oxide synthase gene expression in brain following cerebral ischemia. J. cerebr. Blood Flow. Metab. 15:1995;378-384.
38. Iadecola C. Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci. 20:1997;132-139.
39. Ischiropoulos H., Zhu L., Chen J., Tsai M., Martin J. C., Smith C. D., Beckman J. S. Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Archs Biochem. Biophys. 298:1992;431-437.
40. Kalb R. G., Agostini J. Molecular evidence for nitric oxide-mediated motor neuron development. Neuroscience. 57:1993;1-8.
41. Kostic V., Jackson-Lewis V., de Bilbao F., Dubois-Dauphin M., Przedborski S. Bcl-2: prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis. Science. 277:1997;559-563.
42. Kunst C. B., Mezey E., Brownstein M. J., Patterson D. Mutations in SOD1 associated with amyotrophic lateral sclerosis cause novel protein interactions. Nature Genet. 15:1997;91-94.
43. Linden D. J., Dawson T. M., Dawson V. L. An evaluation of the nitric oxide/cGMP-dependent protein kinase cascade in the induction of cerebellar long-term depression in culture. J. Neurosci. 15:1995;5098-5105.
44. Marletta M. A. Nitric oxide synthase: aspects concerning structure and catalysis. Cell. 78:1994;927-930.
45. Moncada S., Higgs A. The L-arginine-nitric oxide pathway. New Engl. J. Med. 329:1993;2002-2012.
46. Murphy S., Simmons M. L., Agullo L., Garcia A., Feinstein D. L., Galea E., Reis D. J., Minc-Golomb D., Schwartz J. P. Synthesis of nitric oxide in CNS glial cells. Trends Neurosci. 16:1993;323-328.
47. Nathan C. Nitric oxide as a secretory product of mammalian cells. Fedn Proc. Fedn Am. Socs exp. Biol. 6:1992;3051-3064.
48. Nathan C., Xie Q. W. Nitric oxide synthases: roles, tolls, and controls. Cell. 78:1994;915-918.
49. Nelson R. J., Demas G. E., Huang P. L., Fishman M. C., Dawson V. L., Dawson T. M., Snyder S. H. Behavioural abnormalities in male mice lacking neuronal nitric oxide synthase. Nature. 378:1995;383-386.
50. O'Dell T. J., Huang P. L., Dawson T. M., Dinerman J. L., Snyder S. H., Kandel E. R., Fishman M. C. Endothelial NOS and the blockade of LTP by NOS inhibitors in mice lacking neuronal NOS. Science. 265:1994;542-546.
51. Ogilvie P., Schilling K., Billingsley M. L., Schmidt H. H. Induction and variants of neuronal nitric oxide synthase type I during synaptogenesis. Fedn Proc. Fedn Am. Socs exp. Biol. 9:1995;799-806.
52. Pardo C. A., Xu Z., Borchelt D. R., Price D. L., Sisodia S. S., Cleveland D. W. Superoxide dismutase is an abundant component in cell bodies, dendrites, and axons of motor neurons and in a subset of other neurons. Proc. natn. Acad. Sci. U.S.A. 92:1995;954-958.
53. Peunova N., Enikolopov G. Nitric oxide triggers a switch to growth arrest during differentiation of neuronal cells. Nature. 375:1995;68-73.
54. Przedborski S., Jackson-Lewis V., Yokohama R., Shibata T., Dawson V. L., Dawson T. M. Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Proc. natn. Acad. Sci. U.S.A. 93:1996;4565-4571.
55. Rabizadeh S., Gralla E. B., Borchelt D. R., Gwinn R., Valentine J. S., Sisodia S., Wong P., Lee M., Hahn H., Bredesen D. E. Mutations associated with amyotrophic lateral sclerosis convert superoxide dismutase from an antiapoptotic gene to a proapoptotic gene: studies in yeast and neural cells. Proc. natn. Acad. Sci. U.S.A. 92:1995;3024-3028.
56. Reaume A. G., Elliott J. L., Hoffman E. K., Kowall N. W., Ferrante R. J., Siwek D. F., Wilcox H. M., Flood D. G., Beal M. F., Brown R. H. Jr., Scott R. W., Snider W. D. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nature Genet. 13:1996;43-47.
57. 2+/calmodulin-dependent nitric oxide synthase. Proc. natn. Acad. Sci. U.S.A. 92:1995;9072-9076.
58. Ripps M. E., Huntley G. W., Hof P. R., Morrison J. H., Gordon J. W. Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc. natn. Acad. Sci. U.S.A. 92:1995;689-693.
59. Rosen D. R., Siddique T., Patterson D., Figlewicz D. A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J. P., Deng H. X., Rahamani Z., Krizus A., McKenna-Yasek D., Cayabyab A., Gaston S. M., Berger R., Tanzi R. E., Halperin J. J., Herzfeldt B., Van der Bergh R., Hung W. Y., Bird T., Deng G., Mulder D. W., Smyth C., Laing N. G., Soriano E., Pericak-Vance M. A., Haines J., Rouleau G. A., Gusella J. S., Horovitz H. R., Brown R. H. Jr. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 362:1993;59-62.
60. Samdani A., Dawson T. M., Dawson V. L. Nitric oxide synthase in models of focal ischemia. Stroke. 28:1997;1283-1288.
61. Schulz J. B., Matthews R. T., Muqit M. M., Browne S. E., Beal M. F. Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice. J. Neurochem. 64:1995;936-939.
62. Silvagno F., Xia H., Bredt D. S. Neuronal nitric-oxide synthase-mu, an alternatively spliced isoform expressed in differentiated skeletal muscle. J. biol. Chem. 271:1996;11,204-11,208.
63. Wiedau-Pazos M., Goto J. J., Rabizadeh S., Gralla E. B., Roe J. A., Lee M. K., Valentine J. S., Bredesen D. E. Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science. 271:1996;515-518.
64. Wong P. C., Pardo C. A., Borchelt D. R., Lee M. K., Copeland N. G., Jenkins N. A., Sisodia S. S., Cleveland D. W., Price D. L. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron. 14:1995;1105-1116.
65. Xie J., Roddy P., Rife T. K., Murad F., Young A. P. T. Two closely linked but separable promoters for human neuronal nitric oxide synthase gene transcription. Proc. natn. Acad. Sci. U.S.A. 92:1995;1242-1246.
66. m for hydrogen peroxide. Proc. natn. Acad. Sci. U.S.A. 93:1996;5709-5714.
67. Yoshida T., Limmroth V., Irikura K., Moskowitz M. A. The NOS inhibitor, 7-nitroindazole, decreases focal infarct volume but not the response to topical acetylcholine in pial vessels. J. cerebr. Blood Flow Metab. 14:1994;924-929.
68. Yun H.-Y., Dawson V. L., Dawson T. M. Neurobiology of nitric oxide. Crit. Rev. Neurobiol. 10:1996;291-316.
69. Zhang Z. G., Reif D., Macdonald J., Tang W. X., Kamp D. K., Gentile R. J., Shakespeare W. C., Murray R. J., Chopp M. ARL 17477, a potent and selective neuronal NOS inhibitor decreases infarct volume after transient middle cerebral artery occlusion in rats. J. cerebr. Blood Flow Metab. 16:1996;599-604.